Glass House Brands Inc (NYSE: GLAS) Stock Competitors & Peer Comparison

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TAK has a market cap of 60.2B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TAK trades at $18.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TAK's P/E ratio is 13.60. In terms of profitability, GLAS's ROE is -0.51%, compared to TAK's ROE of +0.02%. Regarding short-term risk, GLAS is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check TAK's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TEVA has a market cap of 45.4B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TEVA trades at $38.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TEVA's P/E ratio is 13.31. In terms of profitability, GLAS's ROE is -0.51%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, GLAS is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check TEVA's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, HLN has a market cap of 40.9B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while HLN trades at $9.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas HLN's P/E ratio is 17.32. In terms of profitability, GLAS's ROE is -0.51%, compared to HLN's ROE of +0.17%. Regarding short-term risk, GLAS is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check HLN's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ZTS has a market cap of 30B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ZTS trades at $71.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ZTS's P/E ratio is 10.86. In terms of profitability, GLAS's ROE is -0.51%, compared to ZTS's ROE of +0.69%. Regarding short-term risk, GLAS is more volatile compared to ZTS. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ZTS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, VTRS has a market cap of 19.7B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while VTRS trades at $16.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas VTRS's P/E ratio is 6.73. In terms of profitability, GLAS's ROE is -0.51%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, GLAS is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check VTRS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ITCI trades at $131.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ITCI's P/E ratio is -180.64. In terms of profitability, GLAS's ROE is -0.51%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, GLAS is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ITCI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CTLT trades at $63.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CTLT's P/E ratio is -27.84. In terms of profitability, GLAS's ROE is -0.51%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, GLAS is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check CTLT's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ELAN has a market cap of 11.2B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ELAN trades at $22.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ELAN's P/E ratio is 21.15. In terms of profitability, GLAS's ROE is -0.51%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, GLAS is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ELAN's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, RDY has a market cap of 10.2B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while RDY trades at $12.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas RDY's P/E ratio is 19.99. In terms of profitability, GLAS's ROE is -0.51%, compared to RDY's ROE of +0.09%. Regarding short-term risk, GLAS is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check RDY's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ALKS has a market cap of 7.8B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ALKS trades at $43.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ALKS's P/E ratio is 49.17. In terms of profitability, GLAS's ROE is -0.51%, compared to ALKS's ROE of +0.04%. Regarding short-term risk, GLAS is less volatile compared to ALKS. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ALKS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, LNTH has a market cap of 6.5B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while LNTH trades at $100.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas LNTH's P/E ratio is 16.90. In terms of profitability, GLAS's ROE is -0.51%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, GLAS is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check LNTH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, AMRX has a market cap of 5.8B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while AMRX trades at $18.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas AMRX's P/E ratio is 20.31. In terms of profitability, GLAS's ROE is -0.51%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, GLAS is less volatile compared to AMRX. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check AMRX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, INDV has a market cap of 4.4B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while INDV trades at $34.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas INDV's P/E ratio is 9.56. In terms of profitability, GLAS's ROE is -0.51%, compared to INDV's ROE of -2.16%. Regarding short-term risk, GLAS is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check INDV's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ALVOW has a market cap of 3B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ALVOW trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ALVOW's P/E ratio is 46.65. In terms of profitability, GLAS's ROE is -0.51%, compared to ALVOW's ROE of +0.77%. Regarding short-term risk, GLAS is less volatile compared to ALVOW. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ALVOW's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, RGC has a market cap of 2.9B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while RGC trades at $5.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas RGC's P/E ratio is -407.75. In terms of profitability, GLAS's ROE is -0.51%, compared to RGC's ROE of -2.32%. Regarding short-term risk, GLAS is less volatile compared to RGC. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check RGC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, SUPN has a market cap of 2.4B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while SUPN trades at $42.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas SUPN's P/E ratio is 13.73. In terms of profitability, GLAS's ROE is -0.51%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, GLAS is less volatile compared to SUPN. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check SUPN's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, HCM has a market cap of 2.4B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while HCM trades at $13.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas HCM's P/E ratio is 5.12. In terms of profitability, GLAS's ROE is -0.51%, compared to HCM's ROE of +0.01%. Regarding short-term risk, GLAS is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check HCM's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while DCPH trades at $25.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas DCPH's P/E ratio is -11.58. In terms of profitability, GLAS's ROE is -0.51%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, GLAS is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check DCPH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while AVDL trades at $21.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, GLAS's ROE is -0.51%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, GLAS is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check AVDL's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, BHC has a market cap of 2.1B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while BHC trades at $5.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas BHC's P/E ratio is 1.45. In terms of profitability, GLAS's ROE is -0.51%, compared to BHC's ROE of +0.89%. Regarding short-term risk, GLAS is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check BHC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while EMBCV trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas EMBCV's P/E ratio is N/A. In terms of profitability, GLAS's ROE is -0.51%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, GLAS is less volatile compared to EMBCV. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check EMBCV's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TRLV has a market cap of 1.9B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TRLV trades at $11.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TRLV's P/E ratio is -4.50. In terms of profitability, GLAS's ROE is -0.51%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, GLAS is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check TRLV's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, PRGO has a market cap of 1.9B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while PRGO trades at $13.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas PRGO's P/E ratio is 5.44. In terms of profitability, GLAS's ROE is -0.51%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, GLAS is less volatile compared to PRGO. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check PRGO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while DVAX trades at $15.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas DVAX's P/E ratio is -41.89. In terms of profitability, GLAS's ROE is -0.51%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, GLAS is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check DVAX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ALVO has a market cap of 1.8B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ALVO trades at $5.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ALVO's P/E ratio is -15.71. In terms of profitability, GLAS's ROE is -0.51%, compared to ALVO's ROE of +0.77%. Regarding short-term risk, GLAS is less volatile compared to ALVO. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ALVO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ANIP trades at $76.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ANIP's P/E ratio is 9.26. In terms of profitability, GLAS's ROE is -0.51%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, GLAS is less volatile compared to ANIP. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ANIP's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TARO trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TARO's P/E ratio is 30.05. In terms of profitability, GLAS's ROE is -0.51%, compared to TARO's ROE of +0.03%. Regarding short-term risk, GLAS is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check TARO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ETON has a market cap of 1.5B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ETON trades at $55.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ETON's P/E ratio is 120.65. In terms of profitability, GLAS's ROE is -0.51%, compared to ETON's ROE of +0.40%. Regarding short-term risk, GLAS is less volatile compared to ETON. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ETON's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while PAHC trades at $34.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas PAHC's P/E ratio is 11.80. In terms of profitability, GLAS's ROE is -0.51%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, GLAS is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check PAHC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CRON has a market cap of 1.3B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CRON trades at $3.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CRON's P/E ratio is 31.81. In terms of profitability, GLAS's ROE is -0.51%, compared to CRON's ROE of +0.06%. Regarding short-term risk, GLAS is more volatile compared to CRON. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check CRON's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, HROW has a market cap of 1.2B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while HROW trades at $33.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas HROW's P/E ratio is -33.41. In terms of profitability, GLAS's ROE is -0.51%, compared to HROW's ROE of -1.04%. Regarding short-term risk, GLAS is less volatile compared to HROW. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check HROW's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, AMPH has a market cap of 1.1B. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while AMPH trades at $23.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas AMPH's P/E ratio is 8.13. In terms of profitability, GLAS's ROE is -0.51%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, GLAS is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check AMPH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, PCRX has a market cap of 971.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while PCRX trades at $24.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas PCRX's P/E ratio is 9.50. In terms of profitability, GLAS's ROE is -0.51%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, GLAS is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check PCRX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while PETQ trades at $30.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas PETQ's P/E ratio is 83.73. In terms of profitability, GLAS's ROE is -0.51%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, GLAS is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check PETQ's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, COLL has a market cap of 738.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while COLL trades at $22.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas COLL's P/E ratio is 2.86. In terms of profitability, GLAS's ROE is -0.51%, compared to COLL's ROE of +0.16%. Regarding short-term risk, GLAS is less volatile compared to COLL. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check COLL's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, IRWD has a market cap of 717.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while IRWD trades at $4.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas IRWD's P/E ratio is 5.59. In terms of profitability, GLAS's ROE is -0.51%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, GLAS is less volatile compared to IRWD. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check IRWD's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, AQST has a market cap of 578.4M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while AQST trades at $4.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas AQST's P/E ratio is -7.09. In terms of profitability, GLAS's ROE is -0.51%, compared to AQST's ROE of +2.44%. Regarding short-term risk, GLAS is less volatile compared to AQST. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check AQST's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while BDSI trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas BDSI's P/E ratio is 6.82. In terms of profitability, GLAS's ROE is -0.51%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, GLAS is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check BDSI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, EVO has a market cap of 568.4M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while EVO trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas EVO's P/E ratio is -2.26. In terms of profitability, GLAS's ROE is -0.51%, compared to EVO's ROE of -0.27%. Regarding short-term risk, GLAS is less volatile compared to EVO. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check EVO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, EOLS has a market cap of 517.6M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while EOLS trades at $7.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas EOLS's P/E ratio is -24.89. In terms of profitability, GLAS's ROE is -0.51%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, GLAS is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check EOLS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, KMDA has a market cap of 510.6M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while KMDA trades at $8.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas KMDA's P/E ratio is 23.29. In terms of profitability, GLAS's ROE is -0.51%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, GLAS is more volatile compared to KMDA. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check KMDA's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TLRY has a market cap of 446.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TLRY trades at $3.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TLRY's P/E ratio is -3.68. In terms of profitability, GLAS's ROE is -0.51%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, GLAS is more volatile compared to TLRY. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check TLRY's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TKNO has a market cap of 417.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TKNO trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TKNO's P/E ratio is -25.13. In terms of profitability, GLAS's ROE is -0.51%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, GLAS is less volatile compared to TKNO. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check TKNO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CGC has a market cap of 394.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CGC trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CGC's P/E ratio is -2.09. In terms of profitability, GLAS's ROE is -0.51%, compared to CGC's ROE of -0.33%. Regarding short-term risk, GLAS is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check CGC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, EBS has a market cap of 349.8M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while EBS trades at $6.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas EBS's P/E ratio is 4.71. In terms of profitability, GLAS's ROE is -0.51%, compared to EBS's ROE of -0.36%. Regarding short-term risk, GLAS is less volatile compared to EBS. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check EBS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ALIM trades at $5.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ALIM's P/E ratio is 5.28. In terms of profitability, GLAS's ROE is -0.51%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, GLAS is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ALIM's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while LNDC trades at $8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas LNDC's P/E ratio is -4.04. In terms of profitability, GLAS's ROE is -0.51%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, GLAS is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check LNDC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ACB has a market cap of 239.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ACB trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ACB's P/E ratio is -2.79. In terms of profitability, GLAS's ROE is -0.51%, compared to ACB's ROE of -0.21%. Regarding short-term risk, GLAS is more volatile compared to ACB. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ACB's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TYHT trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TYHT's P/E ratio is -1.61. In terms of profitability, GLAS's ROE is -0.51%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, GLAS is less volatile compared to TYHT. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check TYHT's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, SIGA has a market cap of 225.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while SIGA trades at $3.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas SIGA's P/E ratio is 11.63. In terms of profitability, GLAS's ROE is -0.51%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, GLAS is less volatile compared to SIGA. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check SIGA's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CRDL has a market cap of 216.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CRDL trades at $1.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CRDL's P/E ratio is -7.47. In terms of profitability, GLAS's ROE is -0.51%, compared to CRDL's ROE of -1.94%. Regarding short-term risk, GLAS is less volatile compared to CRDL. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check CRDL's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, DERM has a market cap of 201.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while DERM trades at $7.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas DERM's P/E ratio is -19.76. In terms of profitability, GLAS's ROE is -0.51%, compared to DERM's ROE of -0.20%. Regarding short-term risk, GLAS is less volatile compared to DERM. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check DERM's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ORGO has a market cap of 182.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ORGO trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ORGO's P/E ratio is 47.33. In terms of profitability, GLAS's ROE is -0.51%, compared to ORGO's ROE of -0.24%. Regarding short-term risk, GLAS is less volatile compared to ORGO. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ORGO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while REPH trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas REPH's P/E ratio is -8.04. In terms of profitability, GLAS's ROE is -0.51%, compared to REPH's ROE of -0.22%. Regarding short-term risk, GLAS is less volatile compared to REPH. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check REPH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, LFCR has a market cap of 167.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while LFCR trades at $4.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas LFCR's P/E ratio is -4.17. In terms of profitability, GLAS's ROE is -0.51%, compared to LFCR's ROE of -3.77%. Regarding short-term risk, GLAS is less volatile compared to LFCR. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check LFCR's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while THTX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas THTX's P/E ratio is -28.83. In terms of profitability, GLAS's ROE is -0.51%, compared to THTX's ROE of +0.36%. Regarding short-term risk, GLAS is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check THTX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ASRT trades at $23.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ASRT's P/E ratio is -7.10. In terms of profitability, GLAS's ROE is -0.51%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, GLAS is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ASRT's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, OGI has a market cap of 147.8M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while OGI trades at $1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas OGI's P/E ratio is 2.36. In terms of profitability, GLAS's ROE is -0.51%, compared to OGI's ROE of +0.21%. Regarding short-term risk, GLAS is less volatile compared to OGI. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check OGI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while SCTL trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas SCTL's P/E ratio is -7.86. In terms of profitability, GLAS's ROE is -0.51%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, GLAS is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check SCTL's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CPIX has a market cap of 109.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CPIX trades at $7.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CPIX's P/E ratio is -18.30. In terms of profitability, GLAS's ROE is -0.51%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, GLAS is less volatile compared to CPIX. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check CPIX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while PROC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas PROC's P/E ratio is 1.53. In terms of profitability, GLAS's ROE is -0.51%, compared to PROC's ROE of -2.22%. Regarding short-term risk, GLAS is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check PROC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, BGM has a market cap of 98.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while BGM trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas BGM's P/E ratio is -0.89. In terms of profitability, GLAS's ROE is -0.51%, compared to BGM's ROE of -0.05%. Regarding short-term risk, GLAS is less volatile compared to BGM. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check BGM's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while OPTN trades at $9.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas OPTN's P/E ratio is -4.42. In terms of profitability, GLAS's ROE is -0.51%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, GLAS is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check OPTN's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ZOM trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ZOM's P/E ratio is -1.62. In terms of profitability, GLAS's ROE is -0.51%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, GLAS is less volatile compared to ZOM. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ZOM's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while GRVI trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas GRVI's P/E ratio is 26.05. In terms of profitability, GLAS's ROE is -0.51%, compared to GRVI's ROE of -4.51%. Regarding short-term risk, GLAS is less volatile compared to GRVI. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check GRVI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ZYNE trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, GLAS's ROE is -0.51%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, GLAS is less volatile compared to ZYNE. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ZYNE's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while SSIC trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas SSIC's P/E ratio is 11.93. In terms of profitability, GLAS's ROE is -0.51%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, GLAS is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check SSIC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ZYBT has a market cap of 64.9M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ZYBT trades at $1.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ZYBT's P/E ratio is -6.23. In terms of profitability, GLAS's ROE is -0.51%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, GLAS is more volatile compared to ZYBT. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ZYBT's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, INCR has a market cap of 62.8M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while INCR trades at $5.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas INCR's P/E ratio is -12.23. In terms of profitability, GLAS's ROE is -0.51%, compared to INCR's ROE of -0.09%. Regarding short-term risk, GLAS is more volatile compared to INCR. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check INCR's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while VLNS trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas VLNS's P/E ratio is -1.03. In terms of profitability, GLAS's ROE is -0.51%, compared to VLNS's ROE of N/A. Regarding short-term risk, GLAS is less volatile compared to VLNS. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check VLNS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TLPH has a market cap of 60.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TLPH trades at $1.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TLPH's P/E ratio is -3.74. In terms of profitability, GLAS's ROE is -0.51%, compared to TLPH's ROE of -0.87%. Regarding short-term risk, GLAS is more volatile compared to TLPH. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check TLPH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while DRRX trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas DRRX's P/E ratio is -4.44. In terms of profitability, GLAS's ROE is -0.51%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, GLAS is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check DRRX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while JUPW trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas JUPW's P/E ratio is -2.41. In terms of profitability, GLAS's ROE is -0.51%, compared to JUPW's ROE of -3.04%. Regarding short-term risk, GLAS is less volatile compared to JUPW. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check JUPW's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while QLI trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas QLI's P/E ratio is -4.92. In terms of profitability, GLAS's ROE is -0.51%, compared to QLI's ROE of -0.16%. Regarding short-term risk, GLAS is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check QLI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, RMTI has a market cap of 31.8M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while RMTI trades at $8.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas RMTI's P/E ratio is -6.02. In terms of profitability, GLAS's ROE is -0.51%, compared to RMTI's ROE of -0.14%. Regarding short-term risk, GLAS is less volatile compared to RMTI. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check RMTI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while HEXO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas HEXO's P/E ratio is -0.26. In terms of profitability, GLAS's ROE is -0.51%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, GLAS is less volatile compared to HEXO. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check HEXO's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CPHI has a market cap of 28.8M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CPHI trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CPHI's P/E ratio is -1.65. In terms of profitability, GLAS's ROE is -0.51%, compared to CPHI's ROE of -0.17%. Regarding short-term risk, GLAS is less volatile compared to CPHI. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check CPHI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, TXMD has a market cap of 25.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while TXMD trades at $2.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas TXMD's P/E ratio is 111.56. In terms of profitability, GLAS's ROE is -0.51%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, GLAS is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check TXMD's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CYTH trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CYTH's P/E ratio is -0.80. In terms of profitability, GLAS's ROE is -0.51%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, GLAS is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check CYTH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, AYTU has a market cap of 22.8M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while AYTU trades at $2.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas AYTU's P/E ratio is -1.10. In terms of profitability, GLAS's ROE is -0.51%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, GLAS is less volatile compared to AYTU. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check AYTU's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while EVOK trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas EVOK's P/E ratio is -7.97. In terms of profitability, GLAS's ROE is -0.51%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, GLAS is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check EVOK's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, OPTH has a market cap of 16.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while OPTH trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas OPTH's P/E ratio is -18.26. In terms of profitability, GLAS's ROE is -0.51%, compared to OPTH's ROE of -0.90%. Regarding short-term risk, GLAS is less volatile compared to OPTH. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check OPTH's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ACRX trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ACRX's P/E ratio is -0.31. In terms of profitability, GLAS's ROE is -0.51%, compared to ACRX's ROE of -0.87%. Regarding short-term risk, GLAS is less volatile compared to ACRX. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ACRX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, CABR has a market cap of 12.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while CABR trades at $1.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas CABR's P/E ratio is -2.50. In terms of profitability, GLAS's ROE is -0.51%, compared to CABR's ROE of -3.86%. Regarding short-term risk, GLAS is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check CABR's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while AGRX trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas AGRX's P/E ratio is -0.89. In terms of profitability, GLAS's ROE is -0.51%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, GLAS is less volatile compared to AGRX. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check AGRX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while NLTX trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas NLTX's P/E ratio is -0.28. In terms of profitability, GLAS's ROE is -0.51%, compared to NLTX's ROE of -0.45%. Regarding short-term risk, GLAS is less volatile compared to NLTX. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check NLTX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while LCI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas LCI's P/E ratio is -0.04. In terms of profitability, GLAS's ROE is -0.51%, compared to LCI's ROE of +1.66%. Regarding short-term risk, GLAS is less volatile compared to LCI. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check LCI's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ADMP trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ADMP's P/E ratio is -0.08. In terms of profitability, GLAS's ROE is -0.51%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, GLAS is less volatile compared to ADMP. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check ADMP's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, GELS has a market cap of 5.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while GELS trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas GELS's P/E ratio is -1.12. In terms of profitability, GLAS's ROE is -0.51%, compared to GELS's ROE of -0.25%. Regarding short-term risk, GLAS is less volatile compared to GELS. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check GELS's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, YCBD has a market cap of 4.7M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while YCBD trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas YCBD's P/E ratio is -1.11. In terms of profitability, GLAS's ROE is -0.51%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, GLAS is less volatile compared to YCBD. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check YCBD's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while MNK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas MNK's P/E ratio is -0.44. In terms of profitability, GLAS's ROE is -0.51%, compared to MNK's ROE of -0.36%. Regarding short-term risk, GLAS is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check MNK's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while FLGC trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas FLGC's P/E ratio is -0.19. In terms of profitability, GLAS's ROE is -0.51%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, GLAS is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check FLGC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, UPC has a market cap of 3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while UPC trades at $4.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas UPC's P/E ratio is -0.60. In terms of profitability, GLAS's ROE is -0.51%, compared to UPC's ROE of -0.03%. Regarding short-term risk, GLAS is less volatile compared to UPC. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check UPC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, IMCC has a market cap of 2.6M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while IMCC trades at $4.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas IMCC's P/E ratio is -2.42. In terms of profitability, GLAS's ROE is -0.51%, compared to IMCC's ROE of +8.42%. Regarding short-term risk, GLAS is less volatile compared to IMCC. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check IMCC's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while PLXP trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas PLXP's P/E ratio is -0.22. In terms of profitability, GLAS's ROE is -0.51%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, GLAS is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check PLXP's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, INM has a market cap of 2.5M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while INM trades at $1.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas INM's P/E ratio is -0.25. In terms of profitability, GLAS's ROE is -0.51%, compared to INM's ROE of -1.35%. Regarding short-term risk, GLAS is more volatile compared to INM. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check INM's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while ATNX trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas ATNX's P/E ratio is -0.02. In terms of profitability, GLAS's ROE is -0.51%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, GLAS is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for GLAS.Check ATNX's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, SNOA has a market cap of 2.2M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while SNOA trades at $1.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas SNOA's P/E ratio is -1.08. In terms of profitability, GLAS's ROE is -0.51%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, GLAS is less volatile compared to SNOA. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check SNOA's competition here

Glass House Brands Inc (NYSE: GLAS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GLAS stands at 614M. In comparison, SBFM has a market cap of 2.1M. Regarding current trading prices, GLAS is priced at $7.97 on the NYSE, while SBFM trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GLAS currently has a P/E ratio of -14.17, whereas SBFM's P/E ratio is -0.15. In terms of profitability, GLAS's ROE is -0.51%, compared to SBFM's ROE of -0.24%. Regarding short-term risk, GLAS is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for GLAS.Check SBFM's competition here